EPTIS
BAM Logo

Immunoreactive trypsinogen newborn screening

[CNN-3 Tripsina inmunorreactiva, cribado neonatal]

EPTIS factsheet 956109 | Last revision 2022-08-31 | URL: https://www.eptis.bam.de/pts956109 https://www.eptis.bam.de/pts956109

PT provider
PT provider Centro de Hemoterapia y Hemodonación de Castilla y León Centro de Hemoterapia y Hemodonación de Castilla y León
Based in Spain
Language(s) English, Spanish
Remarks
Keywords
Product groups Human test material
Testing fields Analytical chemistry
Medical analysis
Technical details
Test item Tested property Testing method
Dry blood spots tripsinogen -
-
Aims of the PT scheme
Target group of participants Newborn screening labs
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 10
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee
Regularly operated Yes (2 monthly)
Year of first operation 2019
Contact details of the PT provider
Provider Contact person
Centro de Hemoterapia y Hemodonación de Castilla y León
Paseo de Filipinos s/n
47007
Spain

Phone: +34983418823
Fax:
Web: https://www.controlcribado.centrodehemoterapiacyl.es https://www.controlcribado.centrodehemoterapiacyl.es
Arancha Barrera
Phone: +34983418823
Fax:
Email: geclid.chem@saludcastillayleon.es geclid.chem@saludcastillayleon.es
If you find any mistakes please contact the responsible EPTIS coordinator in Spain, Mr Miquel Navarro. Mr Miquel Navarro.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5